AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

AJPH First Look, published online ahead of print Nov 30, 2006
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heimer, R.
Right arrow Articles by Singer, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heimer, R.
Right arrow Articles by Singer, M.
Related Collections
Right arrow Health Policy
Right arrow HIV/AIDS
Right arrow Prevention
Right arrow Public Health Practice
Right arrow Surveillance
Right arrow Urban Health
Assessment of HIV Testing of Urban Injection Drug Users: Implications for Expansion of HIV Testing and Prevention Efforts

Robert Heimer, PhD, Lauretta E. Grau, PhD, Erin Curtin, MPH, Kaveh Khoshnood, PhD and Merrill Singer, PhD

Robert Heimer is with the Departments of Epidemiology and Public Health and Pharmacology, Yale University School of Medicine, New Haven, Conn. Lauretta E. Grau and Kaveh Khoshnood are with the Department of Epidemiology and Public Health, Yale University School of Medicine. At the time the study was conducted, Erin Curtin was with the Yale University School of Public Health. Merrill Singer is with the Hispanic Health Council, Hartford, Conn.


Figure 1
View larger version (5K):
[in this window]
[in a new window]
[Download PPT slide]
  		FIGURE 1—— Proportion of injection drug users (IDUs) who had received an HIV test and had never been informed of an HIV seropositive diagnosis, by years since last HIV test: Hartford, Conn; New Haven, Conn; Oakland, Conn; Springfield, Mass; and Chicago, Ill; 1998–2002.

Note. A total of 1130 IDUs reported being tested and did not report having been told that they were infected with HIV. The cumulative frequency of the percentage of these individuals who reported having been tested within a given number of years is represented.

 

Figure 2
View larger version (15K):
[in this window]
[in a new window]
[Download PPT slide]
  		FIGURE 2—— Number of undetected infections among urban intravenous drug users (IDUs) in the United States.

Note. Starting with an estimate for the number of intravenous drug users in the 96 largest urban areas,24 the number of undetected infections among untested and previously tested IDUs is estimated.

 




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Public Health Association